Workflow
donghua test(300354)
icon
Search documents
东华测试:东华测试业绩说明会、路演活动等
2023-03-27 09:11
1 / 2 | | 售副总"销售团队体系。电化学工作站销售团队 30 余人,业 | | --- | --- | | | 务独立。基于 的设备智能维保管理平台主要采用代理商 PHM | | | 销售模式,目前代理商有 16 个。 | | | 2、去年年底教育贴息对行业的影响? | | | 答:公司认为教育贴息对仪器仪表行业有一定的积极促进作 | | | 用,叠加宏观国产替代趋势,将更多利好掌握核心技术的中 | | | 高端国产化仪器厂家。 | | | 3、新技术如何和公司产品相融合? | | | 答:公司追求技术升级,公司最大的技术优势是感知系统, | | | 可靠性高,抗干扰能力强,稳定性高。 | | | 4、公司近几年毛利率净利率上升较快,未来的趋势是怎样 | | | 的? | | | 答:公司以健康运营为目标,未来毛利率净利率不会有太大 | | | 变化。 | | | 5、公司费用端下降较快的原因。 | | | 答:一般而言,多品种小批量生产的费用会比较高,但公司 | | | 不断提升模块化程度、自动化程度,进一步提高定制效率, | | | 从而降低了费用。 | | | 6、请介绍一下公司产能规划情况。 ...
东华测试(300354) - 2022 Q4 - 年度财报
2023-03-09 16:00
Financial Performance - The company's operating revenue for 2022 was ¥367,082,438.42, representing a 42.81% increase compared to ¥257,042,601.70 in 2021[18]. - The net profit attributable to shareholders for 2022 was ¥121,774,983.07, a 52.17% increase from ¥80,023,924.21 in 2021[18]. - The net profit after deducting non-recurring gains and losses was ¥117,372,893.18, up 52.36% from ¥77,039,059.03 in the previous year[18]. - The basic earnings per share for 2022 was ¥0.88, reflecting a 51.72% increase from ¥0.58 in 2021[18]. - The total assets at the end of 2022 amounted to ¥692,310,717.17, a 26.96% increase from ¥545,294,354.68 at the end of 2021[18]. - The net assets attributable to shareholders increased by 21.25% to ¥599,788,943.95 at the end of 2022, compared to ¥494,682,998.00 at the end of 2021[18]. - The company reported a net cash flow from operating activities of ¥31,377,544.40, which is a 14.18% increase from ¥27,481,524.61 in 2021[18]. - The weighted average return on equity for 2022 was 22.17%, up from 17.43% in 2021, indicating improved profitability[18]. Dividend and Shareholder Returns - The company plans to distribute a cash dividend of ¥1.77 per 10 shares to all shareholders, based on a total of 138,320,201 shares[4]. - The cash dividend distribution plan for 2021 was approved, with a cash dividend of 1.75 yuan per 10 shares, totaling 24,482,675.58 yuan[129]. - The total distributable profit for the parent company as of December 31, 2022, is 296,648,991.01 yuan, with a net profit of 106,673,804.92 yuan for the year[129]. Research and Development - The company has developed 19 authorized patents and 45 software copyrights, showcasing its strong R&D capabilities[44]. - The company has implemented a flexible and agile production model to enhance product quality and meet customer demands[40]. - The company is focusing on the development of new products, including the DH5960N rugged high-speed data acquisition system and the DH5981A dual 24-bit AD portable dynamic signal testing and analysis system, among others[96]. - The number of R&D personnel increased to 241 in 2022, up 30.98% from 184 in 2021, with R&D personnel now accounting for 37.31% of the total workforce[69]. - R&D investment amounted to ¥34,621,047.69 in 2022, representing 9.43% of total revenue, a decrease from 10.54% in 2021[69]. Market and Product Development - The company specializes in structural mechanics performance testing and has been focused on intelligent measurement and control systems for nearly 30 years[28]. - The demand for structural mechanics performance testing systems is increasing due to the digital transformation and the need for structural safety in various industries[29]. - The company aims to leverage emerging technologies such as big data and AI to enhance its product offerings and market competitiveness[30]. - The overall market for high-end scientific instruments is expected to expand, driven by national policies supporting R&D investment[29]. - The company has developed a predictive maintenance management platform that integrates health prediction models with IT technology, enhancing equipment management[35]. Operational Efficiency - The company has established a procurement management system to ensure product quality through strict acceptance and inventory procedures[39]. - The company has implemented measures to protect its core technologies, including applying for patents and establishing confidentiality agreements with employees[98]. - The company is addressing rising costs by improving product standardization and quality control, as well as expanding production volumes to reduce unit costs[98]. - The company has established a calibration and testing subsidiary to ensure the accuracy of its instruments throughout their lifecycle[48]. Risk Management - The company has outlined potential risks and countermeasures in its management discussion and analysis section, emphasizing the importance of risk awareness for investors[4]. - The company faces risks related to new product development, including potential delays in market promotion and competition from domestic and international peers[96]. - The company is actively responding to external risks by optimizing organizational structures and enhancing core competitiveness through staff training[97]. Corporate Governance - The company has a supervisory board consisting of 5 members, including 2 employee supervisors, complying with legal and regulatory requirements[102]. - The performance evaluation and incentive mechanism links employee income to work performance, aligning with the company's development status[102]. - The company has established a management system for information disclosure to ensure the accuracy and timeliness of information provided to shareholders[102]. - The governance situation of the company aligns with the requirements of the Company Law and the regulations set by the China Securities Regulatory Commission[103]. Social Responsibility and Sustainability - The company donated 200,000 yuan to the Yangzhou University Education Development Foundation to establish the "Donghua Testing Scholarship Fund" during the reporting period[142]. - The company has implemented an environmental management system and received certification in May 2021, demonstrating its commitment to green and low-carbon development[142]. - The company actively engages in social responsibility initiatives, emphasizing the integration of corporate and social benefits[142]. Financial Management - The company has completed all fundraising projects from its initial public offering, with total raised funds of CNY 195.07 million fully utilized by the end of the reporting period[80]. - The company has a remaining balance of 2,578.4 million in raised funds, which will be used for working capital[83]. - The company has effectively managed cash from idle fundraising, generating some financial returns during the holding period[85]. - The company reported a standard unqualified audit opinion for the financial statements as of December 31, 2022, indicating fair representation of its financial condition and results[195].
东华测试:关于举行2022年度业绩说明会的通知
2023-03-09 11:21
二、会议召开时间和地点 召开时间:2023年3月24日(星期五)下午15:30--17:00 召开方式:现场 证券代码:300354 证券简称:东华测试 公告编号:2023-018 江苏东华测试技术股份有限公司 关于举行2022年度业绩说明会的通知 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚假 记载、误导性陈述或重大遗漏。 江苏东华测试技术股份有限公司(以下简称"公司")2022年年度报告于2023年3月 10日在巨潮资讯网(www.cninfo.com.cn)披露,为了让广大投资者进一步了解公司的经 营业绩、财务状况等情况,加强公司与投资者的沟通互动,公司拟于2023年3月24日(星 期五)下午15:30--17:00召开2022年度业绩说明会。 一、会议类型 本次业绩说明会以现场会议方式召开,公司将针对2022年度的经营成果及财务指标 的具体情况与投资者进行互动交流和沟通,欢迎广大投资者积极参与。 1 五、联系人及联系方式 召开地点:江苏省靖江市新港大道208号(沿江公路罗家港桥东北侧) 三、参会人员 公司董事长、总经理、独立董事、董事会秘书、财务总监及相关部门人员。 四、投资者参加 ...
东华测试(300354) - 2015年12月30日投资者关系活动记录表
2022-12-07 08:34
证券代码:300354 证券简称:东华测试 江苏东华测试技术股份有限公司投资者关系活动记录表 编号:2015-12-30 | --- | --- | --- | |-------------|-------------------------------|--------------------------------------------------------------| | | | | | 投 资 者 关 | □ 特定对象调研 | □ 分析师会议 | | 系 活 动 类 | R 媒体采访 | □ 业绩说明会 | | 别 | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | | | | □ 其他 | | | 参 与 单 位 | 证券时报 记者 张旭升 | | | 名 称 及 人 | 中国基金报 记者 张琳梓 | | | 员姓名 | 益正金融 研究员 赵安 | | | 时间 | 2015 年 12 月 30 日 | 10:00-11:30 | | 地点 | 江苏东华测试技术股份有限公司 | A301 | | 上 市 公 司 | | | | 接 待 人 员 | 董事长刘士钢 | 董秘瞿小松 ...
东华测试(300354) - 东华测试调研活动信息
2022-11-21 15:52
证券代码:300354 证券简称:东华测试 编号:2021-005 江苏东华测试技术股份有限公司 投资者关系活动记录表 | --- | --- | --- | |------------|--------------------------|-------------| | | | | | | 特定对象调研 □分析师会议 | | | 投资者关系 | □媒体采访 | □业绩说明会 | | 活动类别 | □新闻发布会 □路演活动 | | | | 现场参观 □其他 | | 参与单位名称 | --- | --- | |-------------------------|------------------------------------------------------------| | | | | 及人员姓名 | 详见附件清单 | | 时间 2021 | 年 10 月 22 日 下午 15:30-17:30 | | | 地点 江苏东华测试技术股份有限公司 F3 楼会议室 | | 上市公司 接待人员姓名 | 董事长:刘士钢 总经理:熊卫华 董事会秘书:何玲 | | | 一、 公司整体情况介绍 | | | 公司董 ...
东华测试(300354) - 2022 Q1 - 季度财报
2022-04-19 16:00
Revenue and Profitability - The company's revenue for Q1 2022 reached ¥46,512,531.55, representing a 54.92% increase compared to ¥30,023,189.27 in the same period last year[3] - Net profit attributable to shareholders was ¥4,759,001.46, a significant increase of 364.06% from ¥1,025,510.64 in Q1 2021[3] - Basic and diluted earnings per share increased to ¥0.034, up 385.71% from ¥0.007 in the same period last year[3] - Total operating revenue for Q1 2022 was CNY 46,512,531.55, an increase of 54.9% compared to CNY 30,023,189.27 in the same period last year[21] - Net profit for Q1 2022 reached CNY 4,759,001.46, a significant increase from CNY 1,025,510.64 in Q1 2021, representing a growth of 363.5%[23] - The total comprehensive income attributable to the parent company reached ¥4,759,001.46, compared to ¥1,025,510.64 in the previous period, indicating a significant increase[25] - Basic earnings per share increased to ¥0.034 from ¥0.007, reflecting improved profitability[25] Cash Flow and Financial Position - The net cash flow from operating activities improved to -¥15,144,590.79, a 23.14% reduction in losses compared to -¥19,704,932.16 in the previous year[3] - Cash inflow from operating activities totaled ¥47,190,039.46, up from ¥44,398,375.29 in the previous period[28] - Cash outflow from operating activities decreased to ¥62,334,630.25 from ¥64,103,307.45, leading to a net cash flow from operating activities of -¥15,144,590.79, an improvement from -¥19,704,932.16[28] - The net cash flow from investing activities was -¥691,067.00, compared to -¥9,302,743.56 in the previous period, indicating reduced investment outflows[30] - The ending balance of cash and cash equivalents was ¥103,427,209.44, up from ¥89,913,469.03 in the previous period[30] - The company received ¥2,224,964.38 in tax refunds, an increase from ¥1,324,629.74 in the previous period, indicating improved cash flow management[28] Assets and Liabilities - Total assets as of March 31, 2022, were ¥545,728,694.69, a slight increase of 0.08% from ¥545,294,354.68 at the end of the previous year[3] - The company's total liabilities decreased to CNY 42,706,695.24 from CNY 50,611,356.68 year-over-year, a reduction of 15.0%[21] - The company's total liabilities included accounts payable of CNY 11,259,000.70, which increased from CNY 8,179,025.34, reflecting a rise of about 37.5%[17] - The total current assets reached CNY 402,535,912.72, slightly up from CNY 400,473,950.21, marking a growth of about 0.5%[17] - The non-current assets totaled CNY 143,192,781.97, down from CNY 144,820,404.47, which is a decrease of approximately 1.1%[17] Research and Development - The company reported a 63.47% increase in R&D expenses, totaling ¥10,931,601.55, compared to ¥6,687,387.75 in Q1 2021[6] - Research and development expenses for Q1 2022 were CNY 6,833,605.19, an increase of 80.5% compared to CNY 3,791,985.74 in Q1 2021[22] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 6,942, with the largest shareholder holding 48.99% of the shares[9] - The number of restricted shares for major shareholders decreased, with Liu Shigang holding 50,824,447 shares at the end of the period, down from 51,574,447 shares[12] - The total number of restricted shares held by major shareholders at the end of the period was 58,379,594 shares, down from 59,737,319 shares[14] Tax and Government Subsidies - The company experienced a 46.72% decrease in taxes paid, amounting to ¥6,371,788.21, due to tax deferral policies[8] - The company received government subsidies amounting to ¥366,200.00 during the quarter[5] Employee Compensation - The company reported a decrease in employee compensation payable to CNY 3,837,592.80 from CNY 13,518,176.11, a decline of 71.6%[21] - The company paid ¥27,341,249.36 to employees, compared to ¥25,162,528.03 in the previous period, reflecting increased labor costs[28] Audit Status - The company has not undergone an audit for the first quarter report, which may affect the reliability of the financial data presented[31]
东华测试(300354) - 2021 Q3 - 季度财报
2021-10-19 16:00
Financial Performance - The company's operating revenue for the third quarter reached ¥62,953,559.21, an increase of 42.30% compared to the same period last year[6] - Net profit attributable to shareholders was ¥23,996,403.36, reflecting a significant increase of 354.09% year-on-year[6] - The net profit after deducting non-recurring gains and losses was ¥23,385,295.82, up 474.08% from the previous year[6] - The total profit for the period was ¥41,358,147.28, marking a 321.42% increase year-on-year[10] - Net profit for Q3 2021 was ¥39,559,716.53, significantly up from ¥8,755,391.41 in Q3 2020, marking an increase of approximately 351.5%[20] - The company reported a total comprehensive income of ¥39,559,716.53 for Q3 2021, compared to ¥8,755,391.41 in the same quarter last year, indicating a significant increase[21] Earnings and Shareholder Information - The basic earnings per share for the quarter was ¥0.1735, a rise of 354.15% compared to the same quarter last year[6] - Earnings per share for Q3 2021 were ¥0.2860, compared to ¥0.0633 in Q3 2020, representing an increase of approximately 352.3%[21] - The total number of common shareholders at the end of the reporting period is 9,494, with the top 10 shareholders holding 71.91% of the shares[11] - Liu Shigang, the largest shareholder, holds 48.99% of the shares, totaling 67,765,930 shares, with 16,700,000 shares pledged[11] Assets and Liabilities - The total assets at the end of the reporting period amounted to ¥501,696,395.89, representing a 3.05% increase from the end of the previous year[6] - The total assets as of the end of Q3 2021 amounted to ¥501,696,395.89, compared to ¥486,841,455.49 at the end of Q3 2020, showing a growth of about 3.1%[18] - Total liabilities decreased to ¥49,864,005.57 from ¥59,358,010.34 year-over-year, a reduction of approximately 16.0%[18] - The company's equity attributable to shareholders increased to ¥451,832,390.32 from ¥427,483,445.15, reflecting a growth of about 5.7%[18] Cash Flow and Investments - The company's cash flow from operating activities showed a net outflow of ¥5,470,921.34, an improvement of 75.69% compared to the previous year[10] - Operating cash inflow for the current period was CNY 179,112,727.60, an increase of 44.3% compared to CNY 123,947,431.63 in the previous period[23] - Operating cash outflow for the current period was CNY 184,583,648.94, up from CNY 146,448,758.95 in the previous period, resulting in a net cash flow from operating activities of CNY -5,470,921.34[23] - Investment cash outflow totaled CNY 23,397,964.86, compared to CNY 62,932,930.97 in the previous period, leading to a net cash flow from investing activities of CNY -23,392,764.86[24] - Financing cash outflow was CNY 15,215,222.11, an increase from CNY 6,916,010.05 in the previous period, resulting in a net cash flow from financing activities of CNY -15,215,222.11[24] - The net increase in cash and cash equivalents for the current period was CNY -44,079,143.04, compared to CNY -25,320,824.79 in the previous period[24] - The ending balance of cash and cash equivalents was CNY 74,842,001.71, up from CNY 31,282,604.59 in the previous period[24] Research and Development - Research and development expenses increased by 44.17% to ¥18,391,819.82, driven by diversified market demands and increased investment in product technology[9] - Research and development expenses for the period were ¥18,391,819.82, up from ¥12,757,033.42 in the previous year, indicating an increase of approximately 44.3%[20] - The company has ongoing research and development efforts, with intangible assets valued at ¥15,421,980.32[16] Inventory and Receivables - Accounts receivable increased to ¥104,133,525.95 from ¥85,390,641.75 year-over-year[16] - Inventory as of September 30, 2021, is ¥128,375,378.05, up from ¥106,093,358.62 at the end of 2020[16] - The total current assets amount to ¥353,945,414.37, compared to ¥337,640,768.18 at the end of 2020[16] Share Restrictions - The total number of restricted shares at the beginning of the period was 65,800,394, with 6,063,375 shares released during the period[15] - Liu Shigang's restricted shares decreased to 51,574,447 after releasing 6,000,000 shares[15] Other Financial Information - The company experienced a 100% decrease in investment income, primarily due to the absence of bank financial products purchased in the same period last year[10] - The company received tax refunds of CNY 6,305,140.39, an increase from CNY 3,596,216.12 in the previous period[23] - The company paid CNY 64,104,767.13 to employees, which is an increase from CNY 45,100,490.55 in the previous period[23] - The company did not require adjustments to the initial balance sheet due to the new leasing standards, as there were no affected business operations[25] - The third quarter report was not audited[26]
东华测试(300354) - 2021 Q2 - 季度财报
2021-08-02 16:00
Financial Performance - The company's operating revenue for the first half of 2021 was ¥102,545,436.01, representing a 47.23% increase compared to ¥69,651,951.17 in the same period last year[29]. - The net profit attributable to shareholders was ¥15,563,313.17, a significant increase of 348.40% from ¥3,470,877.27 in the previous year[29]. - The net profit after deducting non-recurring gains and losses reached ¥14,803,999.00, up 917.82% from ¥1,454,476.17 year-on-year[29]. - The basic earnings per share increased to ¥0.113, reflecting a growth of 352.00% compared to ¥0.025 in the same period last year[29]. - The net cash flow from operating activities improved to -¥11,777,781.54, a 58.84% reduction in losses from -¥28,614,315.55 in the previous year[29]. - The company reported a total profit of ¥17,231,615.44 for the first half of 2021, a substantial increase from ¥4,292,255.79 in the previous year[198]. - Operating costs increased to ¥87,391,268.52, representing a rise of 30.1% from ¥67,160,519.40 in the previous year[194]. - Research and development expenses for the first half of 2021 were ¥12,566,127.88, an increase of 8.0% compared to ¥11,642,881.92 in the first half of 2020[194]. - The company has seen a significant increase in tax expenses, with a 103.11% rise to ¥1,668,302.27, due to increased profits[58]. Assets and Liabilities - Total assets at the end of the reporting period were ¥480,837,547.13, a slight decrease of 1.23% from ¥486,841,455.49 at the end of the previous year[29]. - The net assets attributable to shareholders were ¥427,835,986.96, showing a marginal increase of 0.08% from ¥427,483,445.15 at the end of the previous year[29]. - Total liabilities decreased to ¥53,001,560.17 from ¥59,358,010.34, a reduction of about 10.0%[185]. - The company's equity attributable to shareholders increased slightly to ¥427,835,986.96 from ¥427,483,445.15, showing a growth of 0.8%[187]. - Cash and cash equivalents decreased to ¥81,556,002.56 from ¥119,122,529.87, representing a decline of about 31.5%[181]. - Accounts receivable increased to ¥99,289,967.89, up 16.3% from ¥85,390,641.75[181]. - Inventory rose to ¥117,028,449.24, an increase of 10.5% compared to ¥106,093,358.62[181]. Research and Development - The company holds 62 authorized patents and software copyrights, showcasing its strong R&D capabilities in structural mechanics testing technology[44]. - The company has developed a predictive maintenance management platform based on PHM, enhancing its service offerings in equipment health management[38]. - The company has developed a comprehensive product line in structural mechanics performance testing, including portable, handheld, and wireless testing systems[50]. - The company has developed and accumulated several core technologies through continuous R&D, with most being at a leading domestic or advanced international level[96]. - The company has applied for patents for some core technologies and has implemented confidentiality agreements with employees to protect its core technologies[96]. Market Position and Strategy - The company is positioned in a growing industry with increasing demand for scientific instruments due to rising national research investments and technological advancements[43]. - The company employs a direct sales model, utilizing various channels to strengthen customer communication and market presence[41]. - To enhance market share and maintain industry leadership, the company has increased sales, management, and R&D expenses, which will lead to higher operating costs[95]. - The company plans to improve product standardization and quality control to reduce unit production costs and develop a remote service platform to lower service costs[95]. Corporate Governance and Compliance - The company has established a comprehensive internal control system to protect investor rights and ensure timely and accurate information disclosure[114]. - The company has implemented a health and safety management system, achieving certification in occupational health and safety management[115]. - The company has been recognized as a AAA-level enterprise for quality credit by the Jiangsu Provincial Market Supervision Administration[116]. - The company reported that the actual controller and major shareholders have fulfilled their commitments during the reporting period, with no overdue commitments as of the end of the reporting period[121]. - The company has no non-operating fund occupation by controlling shareholders or related parties during the reporting period[128]. - There were no major litigation or arbitration matters during the reporting period[132]. - The company did not experience any violations of external guarantees during the reporting period[129]. Shareholder Information - The total number of shares before the change was 138,320,201, with 47.57% being limited shares and 52.43% being unrestricted shares[155]. - The number of limited shares decreased by 6,063,375, resulting in a total of 59,737,019 limited shares, which is 43.19% of the total[155]. - The number of unrestricted shares increased by 6,063,375, leading to a total of 78,583,182 unrestricted shares, which is 56.81% of the total[155]. - Liu Shigang holds 48.99% of the shares, totaling 67,765,930, with 51,574,447 being limited shares[160]. - The company has 9,902 shareholders holding 5% or more of the shares as of the reporting period[160]. - The company has not implemented any share buyback or repurchase plans during the reporting period[157]. - The total number of shares held by the top 10 shareholders includes significant limited shares, indicating a concentrated ownership structure[160]. Investment and Projects - The company has invested RMB 1,000,000 to establish a wholly-owned subsidiary for the intelligent electrochemical analysis instrument project, which is currently in progress[78]. - The company allocated RMB 3,500,000 for the construction of the intelligent electrochemical analysis instrument production base, with 99.96% of the project completed[78]. - The cumulative investment in committed projects reached RMB 10,371,080.00, with an investment progress of 100%[76]. - The company has not achieved the expected benefits from the projects as planned[76]. - The mechanical equipment and device operation status monitoring system project has been postponed to December 31, 2021, due to adjustments in implementation progress and market conditions[78]. - The testing technology center project is also delayed until December 31, 2021, to enhance product competitiveness and adapt to changing market demands[78].